Generation Bio Co
NASDAQ:GBIO

Watchlist Manager
Generation Bio Co Logo
Generation Bio Co
NASDAQ:GBIO
Watchlist
Price: 5.49 USD -0.9% Market Closed
Market Cap: 37m USD

Operating Margin
Generation Bio Co

-589.6%
Current
-2 041%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-589.6%
=
Operating Profit
-90m
/
Revenue
15.3m

Operating Margin Across Competitors

No Stocks Found

Generation Bio Co
Glance View

Market Cap
37m USD
Industry
Biotechnology

Generation Bio Co. is a genetic medicine company focused on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 150 full-time employees. The company went IPO on 2020-06-12. The firm through its non-viral genetic medicine platform, is engaged in developing genetic medicines to provide genetic payloads, which include large and multiple genes to a range of cell types across a range of diseases. The company is comprised of three component technologies: ceDNA, ctLNP and ceDNA manufacturing process. ceDNA is an engineered, double-stranded, linear, covalently closed-ended deoxyribonucleic acid (DNA) construct, which includes the gene of interest and associated regulatory sequences. The company has produced ceDNA constructs of approximately eight kilobases. Its ctLNP delivery system builds upon clinically validated lipid nanoparticles and is designed to allow for repeat dosing of a genetic payload without stimulating an immune response, such as antibody production. Its ceDNA manufacturing process uses its own cell-free rapid enzymatic synthesis (RES) to produce ceDNA.

GBIO Intrinsic Value
6.19 USD
Undervaluation 11%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-589.6%
=
Operating Profit
-90m
/
Revenue
15.3m
What is the Operating Margin of Generation Bio Co?

Based on Generation Bio Co's most recent financial statements, the company has Operating Margin of -589.6%.

Back to Top